INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, vol.4, no.4, pp.402-405, 2011 (SCI-Expanded)
AIM: To evaluate prospectively immediate intraocular pressure (IOP) changes after the intravitreal injection of ranibizumab, 2 and 4mg triamcinolone acetonide.